#Spain #Barcelona #Antibiotics #IBS #UEG Week

Antibiotics and Irritable Bowel Syndrome: A Closer Look

Recent research presented at UEG Week 2026 has stirred significant attention regarding the relationship between antibiotic prescriptions during childhood and the development of Irritable Bowel Syndrome (IBS) in young adulthood. This study specifically highlights the risks associated with antibiotic use between the ages of 9 and 24.

The Study's Background

Conducted in Sweden, the research analyzed data from the BAMSE birth cohort, which included over 2,800 participants. The participants' antibiotic prescriptions were tracked from 2005 until they reached the age of 24, allowing researchers to correlate antibiotic exposure with the incidence of IBS. At age 24, about 10% of the participants reported experiencing IBS symptoms.

Key Findings

The findings demonstrated a clear link between antibiotic usage in childhood and young adulthood and the likelihood of developing IBS. Notably, 87.8% of participants with IBS had received antibiotics compared to 80.2% of those without IBS. When accounting for various factors such as gender and socioeconomic status, having been prescribed antibiotics increased the odds of developing IBS by 1.5 times. The risk escalated with the number of prescriptions:

• - One or two prescriptions: 1.3 times increased risk
• - Three to five prescriptions: 1.6 times increased risk
• - Six or more prescriptions: 1.7 times increased risk

Among the different classes of antibiotics studied, tetracyclines and cephalosporins were notably associated with higher risks of IBS following the necessary adjustments for potential confounders. Individuals who used tetracyclines showed a 1.4 times increased risk, and those who received three or more cephalosporin prescriptions had a staggering 6.0 times increased likelihood of developing IBS.

The Role of the Gut Microbiome

While the exact mechanism through which antibiotics contribute to IBS remains uncertain, Dr. Jessica Sjölund, the study's lead author, suggested that antibiotics may disrupt the gut microbiome, a vital aspect of gut health. Previous studies have established that alterations in gut microbiota are linked to IBS, proposing this disruption as a plausible pathway explaining the observed association.

Implications for Prescribing Practices

Dr. Sjölund underscored the importance of balancing the therapeutic benefits of antibiotics against their potential long-term effects. She emphasized that antibiotics play a crucial role in treating bacterial infections and their essential use should not be hindered. However, the findings from this study push for a more judicious approach to prescribing antibiotics, particularly in children who might be more susceptible to the long-term consequences of such medications.

Conclusion

As the findings from this study reverberate through medical communities, they will likely encourage healthcare professionals to reassess antibiotic prescribing patterns. The ongoing dialogue around antibiotic stewardship emphasizes the need for caution, particularly with pediatric patients, as we seek to navigate the fine line between effective treatment and the unintended consequences of medication.

The association between early antibiotic exposure and the risk of IBS poses an important consideration for future research and clinical practices aimed at optimizing health and preventing gastrointestinal disorders in young adults.